Allgens Medical Technology CO., LTD. (SHSE: 688613)
Health Care · Health Care Equipment & Supplies · CN
CN¥15.45
-0.45% today · -25.3% 1Y
Allgens Medical Technology CO., LTD. (SHSE: 688613) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $314.88M and employs 281 people.
Over the last twelve months the share price has lost 25.3%, trading between 12.94 and 29.88.
Tweenvest scores Allgens Medical Technology CO., LTD. across four factors: quality 66/100, value 65/100, growth 40/100, dividend 11/100. Its strongest factor is quality.
688613 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $314.88M
- Revenue (TTM)
- $33.34M
- P/E
- 160.53
- EPS
- 0.10
- Dividend yield
- 0.20%
- Beta (5Y)
- 0.58
- 52-week high
- CN¥29.88
- 52-week low
- CN¥12.94
- Avg volume (3M)
- —
- Shares outstanding
- 137.01M
- Employees
- 281
- Next earnings
- —
About Allgens Medical Technology CO., LTD.
Allgens Medical Technology Co. Ltd. operates as a medical device firm, concentrating on the development and production of sophisticated biomimetic synthetic bone graft systems. These innovative solutions are engineered for global deployment in areas where both cancellous (spongy) and cortical (dense outer layer) bone tissues have been compromised. The company's diverse product portfolio includes key offerings such as BonGold, a mineralized collagen scaffold designed for bone grafting procedures; the high-performance Alligator bone marrow aspirator; and OssaNova, a mineralized collagen-based material utilized for bone filling and augmentation. These products are broadly applied across a spectrum of orthopedic and skeletal repair interventions throughout the human anatomy. Allgens Medical Technology Co. Ltd. was established in 2004 and is headquartered in Beijing, China.
- Founded
- 2004
- Listed since
- May 21, 2021
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.64 | +2.19% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $378.81 | +1.19% |
| Stryker CorporationNYSE: SYK | $126.37B | $329.45 | +0.53% |
| Medtronic plcNYSE: MDT | $119.49B | $93.35 | +1.14% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €162.35 | -0.52% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.37 | +2.03% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.